Italy Allergy Treatment Market Overview, 2030

The market for allergy treatment in Italy is expanding due to a rise in the occurrence of allergic disorders. Recent years have seen a significant increase in cases related to allergies, particularly respiratory issues like hay fever, asthma, and allergic rhinitis, which are greatly impacted by exposure to pollen and pollution in urban areas. Research shows that approximately one in three people in Italy suffer from some type of allergy, making it a major public health concern in the region. Seasonal factors, along with changes in lifestyle and increased awareness, are contributing to a higher demand for effective therapies among all age groups. Conventional allergy medications, such as antihistamines, decongestants, nasal corticosteroid sprays, and topical ointments, remain prevalent in prescriptions and over-the-counter purchases. These remedies are easily accessible through pharmacies, which act as the main source for treating mild to moderate allergy issues. Italy boasts a strong pharmacy infrastructure, ensuring that even smaller communities and rural regions can obtain essential allergy treatment. Nevertheless, the dependence on short-term symptom alleviation has revealed the drawbacks of standard medications, especially for individuals dealing with chronic or severe allergies. This situation has created chances for more advanced options like immunotherapy and biologics. Subcutaneous and sublingual immunotherapy are becoming more popular in Italy, particularly for allergies related to pollen, as allergists recommend them for long-lasting relief and a chance to change the disease's trajectory. Treatments such as monoclonal antibodies for severe asthma and atopic dermatitis are also increasingly utilized in hospitals, indicating a transition towards personalized and targeted medical approaches. Investment in healthcare and greater public awareness are propelling the market's growth. Italian hospitals and specialty clinics are enhancing allergy treatment services, while continuous patient education efforts encourage early diagnosis and adherence to treatment.

According to the research report, ""Italy Allergy Treatment Market Overview, 2030,"" published by Bonafide Research, the Italy Allergy Treatment market is anticipated to add to more than USD 320 Million by 2025–30. The allergy treatment sector in Italy is set to experience expansion, fueled by improvements in treatment methods and better access to healthcare. There has been a consistent increase in allergy cases among all demographics, leading to a heightened need for effective solutions. Conditions such as allergic rhinitis, asthma, atopic dermatitis, and food allergies are being increasingly identified in both city and rural residents, driven by environmental influences, changes in diet, and genetic factors. The Italian healthcare system is responding to the growing acknowledgment of allergies as a chronic health issue by broadening treatment access and investing in specialized healthcare. Innovations in pharmaceuticals are a key driver of this market growth. Although antihistamines, corticosteroids, and decongestants remain the most widely used prescription and over-the-counter options, there is a noticeable trend toward more advanced treatment therapies. Immunotherapy, both sublingual and subcutaneous, is becoming increasingly popular in Italy, particularly for allergies related to pollen that peak during the spring and summer months. These long-term treatments not only lessen the intensity of symptoms but also alter immune reactions, granting patients an opportunity for improved quality of life. Biologic treatments like monoclonal antibodies for severe asthma and chronic hives are expanding the variety of available options, especially in hospital environments. Better healthcare systems and easier access also bolster market expansion. Italy’s widespread network of pharmacies makes basic allergy medications readily accessible, while hospitals and specialized clinics offer high-level care. Collaboration between public and private sectors is fostering educational initiatives that promote prompt diagnosis and adherence to long-term therapies.

Italy allergy treatment market by type is divided into Eye Allergy, Skin Allergy, Food Allergy and Other Allergies is observing a rise in food allergy incidents, coupled with heightened awareness regarding skin and respiratory allergies. Among public health issues, food allergies rank among the most critical, especially in young children. Common allergens include cow’s milk, eggs, peanuts, tree nuts, and shellfish, which frequently result in serious reactions necessitating urgent medical intervention. The greater access to and recognition of epinephrine auto-injectors, paired with more rigorous food labeling laws, highlight the increased focus on controlling food allergies in Italy. The uptick in cases has also propelled research into oral immunotherapy and desensitization methods, which are slowly being integrated into specialized allergy treatment centers. Skin allergies, such as atopic dermatitis, eczema, and contact dermatitis, are quite prevalent as well. Factors like urban pollution, changes in climate, and shifts in lifestyle have worsened these conditions, leading to a higher request for topical corticosteroids, antihistamines, and biologics, including dupilumab. The rising focus on dermatological care in hospitals and the accessibility of specialized skincare items in pharmacies have positioned skin allergy treatments as a rapidly growing category in the Italian market. Respiratory allergies, including allergic rhinitis and asthma, continue to be a major issue. Hay fever related to pollen peaks in the spring and summer months, impacting millions of Italians, especially in areas rich in vegetation. Asthma treatment has progressed through the use of inhaled corticosteroids, bronchodilators, and newer biologics tailored for severe cases. Both subcutaneous and sublingual immunotherapy is commonly utilized for respiratory allergies and is gaining traction for its long-lasting advantages. Eye allergies, mainly allergic conjunctivitis, although less highlighted than food and respiratory allergies, are becoming more significant because of longer pollen seasons and urban air quality problems.

In Italy allergy treatment by treatment type is divided into Anti-Allergy Drugs and Immunotherapy. Conventional anti-allergy drugs remain the primary choice for patients across the nation. Medications such as antihistamines, corticosteroids, decongestants, and leukotriene antagonists are essential for managing health issues like allergic rhinitis, asthma, conjunctivitis, and atopic dermatitis. Their cost-effectiveness, quick relief, and general availability in pharmacies contribute to their ongoing popularity. Particularly during high pollen periods, over-the-counter medications are frequently sought by millions of Italians looking for prompt alleviation from hay fever and other allergy-related respiratory issues. In spite of the strong reliance on pharmaceutical treatments, immunotherapy is steadily gaining traction, especially in specialized allergy clinics and hospital environments across Italy. Subcutaneous immunotherapy allergy injections and sublingual immunotherapy SLIT tablets are increasingly being suggested for individuals suffering from chronic allergies, notably those induced by pollen, dust mites, and pet hair. These treatment options provide lasting advantages by altering the immune response rather than just alleviating symptoms. Although the uptake remains relatively low when compared to traditional drugs, specialist awareness is growing as clinical research continues to validate the effectiveness of immunotherapy in minimizing symptoms and preventing the escalation to more serious ailments such as asthma. Biological treatments are also starting to transform the approach to serious allergy cases in Italy. Monoclonal antibodies like omalizumab and dupilumab are being administered to patients afflicted with chronic urticaria, severe asthma, or atopic dermatitis that do not respond effectively to standard treatments. While their use is limited due to high expenses and availability primarily through hospital pharmacies, biologic therapies illustrate Italy’s gradual movement towards tailored medical care. While pharmaceutical treatments are prevalent in Italy's daily allergy care, the increasing embrace of immunotherapy and biologics signifies a shift toward sustainable and targeted approaches, reflecting the development of the country’s healthcare methods for long-term allergic conditions.

Italy's allergy treatment market by distribution channels by distribution channel is divided into Hospital Pharmacies, Retail Pharmacies, Online Retailers and Others. Retail pharmacies are robust, yet hospital services offer advanced treatment options. In Italy, community and retail pharmacies are fundamental to distributing allergy treatments, acting as the main providers for both prescription and over-the-counter remedies. Antihistamines, corticosteroid nasal sprays, topical ointments, and eye drops are broadly accessible through a wide pharmacy network, making them reachable even in smaller towns and remote areas. The convenience, cost-effectiveness, and guidance from pharmacists at retail pharmacies make them the go-to choice for most individuals dealing with seasonal or mild to moderate allergies. During high pollen seasons, sales of OTC products spike, underscoring the important status of retail shops in common allergy management. Hospital-associated pharmacies are essential in handling more severe and complicated allergy scenarios. These establishments are crucial for distributing biologics and facilitating immunotherapy, which necessitates specialist supervision and clinical oversight. Patients suffering from severe asthma, chronic hives, or atopic dermatitis frequently depend on hospital pharmacies for advanced treatments that are less available in retail environments. The collaboration between allergy specialists and pharmacy services in hospitals improves treatment accuracy and guarantees ongoing care, establishing these facilities as vital for high-risk patients. Online pharmacies are progressively becoming a distribution method, propelled by the expansion of Italy's e-health framework. Although uptake is slower compared to countries like the UK or Germany, rising consumer preferences for convenience and home delivery are boosting digital pharmacy services. Individuals with chronic illnesses are starting to utilize these platforms for consistent refills of allergy medications. Other specialized distributors and clinics also play a small role, especially for specific immunotherapy solutions.

Considered in this report
• Historic Year: 2019
• Base year: 2024
• Estimated year: 2025
• Forecast year: 2030

Aspects covered in this report
• Allergy Care Market with its value and forecast along with its segments
• Various drivers and challenges
• On-going trends and developments
• Top profiled companies
• Strategic recommendation

By Type
• Eye Allergy
• Skin Allergy
• Food Allergy
• Other Allergies

By Treatment Type
• Anti-Allergy Drugs
• Immunotherapy

By Distribution Channels
• Hospital Pharmacies
• Retail Pharmacies
• Online Retailers
• Others Show more